companydata.dkcompanydata.dk

Reumatolog Khurram Ashraf ApS: Financial statements 2023

CVR: 39336081

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

Reumatolog Khurram Ashraf ApS (CVR 39336081) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 411,666 and a net result of DKK -167,538 compared with DKK 349,297 the year before. That is a decrease of 30.8% compared with the year before. Equity in the 2023 report amounted to DKK -124,169. The company had 1 employee in the financial year.

Gross Profit
DKK 411,666
Profit/Loss
DKK -167,538
Equity
DKK -124,169
Total Assets
DKK 544,479
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-412K-168K-124K1
2022-595K349K393K-
2021-525K404K444K-
2020-354K279K319K-
2019-165K128K165K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Reumatolog Khurram Ashraf ApS: The 2022 annual report is outJun 22, 2023

Reumatolog Khurram Ashraf ApS has published its annual report for 2022. Gross profit came to DKK 594,995, and the net result was DKK 349,297.

About Reumatolog Khurram Ashraf ApS

Reumatolog Khurram Ashraf ApS is a Danish company of the type Anpartsselskab based in Hillerød, founded in 2018. The company is registered under the industry Alment praktiserende lægers aktiviteter. The company was previously named Reumatolog Khurram Ashraf IVS. The management consists of Khurram Ashraf. The company is owned by Speciallægen FZJ Holding ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 633,663 and a net result of DKK 130,666 compared with DKK 46,332 the year before. Equity in the 2025 report amounted to DKK 52,832.

Source: annual report 2025, Danish Business Authority

Other financial years